Ipsapirone

This classification denotes a serotonin agonist and anxiolytic with the molecular formula C19H23N5O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6J9B11MN0K, chemically known as 1,2-benzisothiazol-3(2h)-one, 2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, 1,1-dioxide but generally known as ipsapirone, which bears US NIH Compound Identifier 56971. European Medicines Agency schedules Ipsapirone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08290MIG. The term IPSAPIRONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). Most nations schedule ipsapirone under HS 29341000 and SITC 51579. As of Q4 2014, IPSAPIRONE remains the US FDA Preferred Term for this commodity. Ipsapirone bears US NLM identifiers UMLS ID C0123905 and NCI Concept Code C74391. SMILES: S1(=O)(=O)N(CCCCN2CCN(CC2)C2NCCCN2)C(=O)C2C1CCCC2.